Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cervical Cancer
  Free Subscription

Articles published in
Clin Cancer Res
    May 2024
  1. SHETH SS, Oh JE, Bellone S, Siegel ER, et al
    Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
    Clin Cancer Res. 2024;30:1768-1777.
    >> Share

    April 2024
  2. SIVARS L, Jylha C, Crona Guterstam Y, Zupancic M, et al
    Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer.
    Clin Cancer Res. 2024 Apr 26. doi: 10.1158/1078-0432.CCR-23-3941.
    >> Share

  3. CHAMBERS L, Haight P, Chalif J, Mehra Y, et al
    Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-Oncology Research.
    Clin Cancer Res. 2024 Apr 25. doi: 10.1158/1078-0432.CCR-23-2570.
    >> Share

    February 2024
  4. LOU H, Cai H, Huang X, Li G, et al
    Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study.
    Clin Cancer Res. 2024 Feb 19. doi: 10.1158/1078-0432.CCR-23-3162.
    >> Share

    January 2024
  5. LUKOVIC J, Pintilie M, Han K, Fyles AW, et al
    An immune gene expression risk score for distant metastases after radiotherapy for cervical cancer.
    Clin Cancer Res. 2024 Jan 5. doi: 10.1158/1078-0432.CCR-23-2085.
    >> Share

  6. OAKNIN A, Ghamande SA, Kasamatsu Y, Gil-Martin M, et al
    Phase 1 trial of first-line bintrafusp alfa in patients with locally advanced or persistent/recurrent/metastatic cervical cancer.
    Clin Cancer Res. 2024 Jan 2. doi: 10.1158/1078-0432.CCR-23-1829.
    >> Share

    August 2023
  7. FRIEDMAN CF, Ravichandran V, Miller K, Vanderbilt C, et al
    Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
    Clin Cancer Res. 2023 Aug 29:CCR-23-1078. doi: 10.1158/1078-0432.CCR-23-1078.
    >> Share

    December 2022
  8. LYNG H, Skipar K, Hompland T
    Targeted Therapy on the Screen: Do We Hit the Target?
    Clin Cancer Res. 2022;28:5233-5234.
    >> Share

    November 2022
  9. HILLEMANNS P, Denecke A, Woelber L, Bohmer G, et al
    A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial.
    Clin Cancer Res. 2022;28:4885-4892.
    >> Share

    October 2022
  10. GHOSH S, Mazumdar T, Xu W, Powell RT, et al
    Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers.
    Clin Cancer Res. 2022;28:4479-4493.
    >> Share

    September 2022
  11. AN J, Tang J, Li BX, Xiong H, et al
    Efficacy and Safety of the Anti-PD-L1 Monoclonal Antibody Socazolimab for Recurrent or Metastatic Cervical Cancer: A Phase I Dose-Escalation and Expansion Study.
    Clin Cancer Res. 2022 Sep 22. pii: 709354. doi: 10.1158/1078-0432.CCR-22-1280.
    >> Share

    August 2022
  12. HAN K, Fyles A, Shek T, Croke J, et al
    A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.
    Clin Cancer Res. 2022 Aug 29. pii: 708819. doi: 10.1158/1078-0432.CCR-22-1665.
    >> Share

  13. MILLER KM, Friedman CF
    Bifunctional Blockade: A Novel Immunotherapy Approach for Cervical Cancer.
    Clin Cancer Res. 2022 Aug 10. pii: 707611. doi: 10.1158/1078-0432.CCR-22-1779.
    >> Share

    June 2022
  14. FENG J, Tang D, Wang J, Zhou Q, et al
    SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, for recurrent or metastatic cervical cancer: a clinical expansion cohort of phase 1 study.
    Clin Cancer Res. 2022 Jun 2. pii: 699316. doi: 10.1158/1078-0432.CCR-22-0346.
    >> Share

    March 2022
  15. VAN DEN HELDER R, Steenbergen RDM, van Splunter AP, Mom CH, et al
    HPV AND DNA METHYLATION TESTING IN URINE FOR CERVICAL INTRAEPITHELIAL NEOPLASIA AND CERVICAL CANCER DETECTION.
    Clin Cancer Res. 2022 Mar 10. pii: 682143. doi: 10.1158/1078-0432.CCR-21-3710.
    >> Share

    September 2021
  16. ROCKALL AG, Barwick TD, Wilson W, Singh N, et al
    DIAGNOSTIC ACCURACY OF FEC-PET/CT, FDG-PET/CT AND DIFFUSION-WEIGHTED MRI IN DETECTION OF NODAL METASTASES IN SURGICALLY TREATED ENDOMETRIAL AND CERVICAL CARCINOMA.
    Clin Cancer Res. 2021 Sep 15. pii: 1078-0432.CCR-21-1834.
    >> Share

    August 2021
  17. WILLIAMSON CW, Zamarin D, Mayadev J
    Standardized Uptake Value Illuminates Tumor Inflammation and Treatment Response.
    Clin Cancer Res. 2021;27:4136-4138.
    >> Share

    July 2021
  18. MONDINI M, Deutsch E
    (Chemo)Radiotherapy-Immunotherapy Combinations: Time to Get Tailored?
    Clin Cancer Res. 2021;27:3815-3817.
    >> Share

  19. JEANNOT E, Latouche A, Bonneau C, Calmejane MA, et al
    Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer.
    Clin Cancer Res. 2021 Jul 1. pii: 1078-0432.CCR-21-0625.
    >> Share

    April 2021
  20. FERRALL L, Lin KY, Roden RBS, Hung CF, et al
    Cervical Cancer Immunotherapy: Facts and Hopes.
    Clin Cancer Res. 2021 Apr 22. pii: 1078-0432.CCR-20-2833.
    >> Share

  21. FLOBERG JM, Zhang J, Muhammad N, DeWees TA, et al
    Standardized Uptake Value for 18F-Fluorodeoxyglucose is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer.
    Clin Cancer Res. 2021 Apr 5. pii: 1078-0432.CCR-20-4450.
    >> Share

    March 2021
  22. CHEN J, Chen C, Zhan Y, Zhou L, et al
    Heterogeneity of interferon-mediated responses and tumor immunogenicity in cervical cancer patients receiving concurrent chemoradiotherapy.
    Clin Cancer Res. 2021 Mar 25. pii: 1078-0432.CCR-20-4521.
    >> Share

    April 2020
  23. CHOI YJ, Hur SY, Kim TJ, Hong SR, et al
    A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3.
    Clin Cancer Res. 2020;26:1616-1623.
    >> Share

    December 2019
  24. LI F, Zhang Z, Cai J, Chen X, et al
    Primary preclinical and clinical Evaluation of 68Ga-DOTA-TMVP1 as a novel VEGFR-3 PET Imaging Radiotracer in Gynecological Cancer.
    Clin Cancer Res. 2019 Dec 16. pii: 1078-0432.CCR-19-1845.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016